Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=18318466
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\18318466
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Med+Chem
2008 ; 51
(6
): 1706-18
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent
naphthoquinone-based inhibitors
#MMPMID18318466
Kumar S
; Malachowski WP
; DuHadaway JB
; LaLonde JM
; Carroll PJ
; Jaller D
; Metz R
; Prendergast GC
; Muller AJ
J Med Chem
2008[Mar]; 51
(6
): 1706-18
PMID18318466
show ga
Indoleamine 2,3-dioxygenase (IDO) is emerging as an important new therapeutic
target for the treatment of cancer, chronic viral infections, and other diseases
characterized by pathological immune suppression. While small molecule inhibitors
of IDO exist, there remains a dearth of high-potency compounds offering in vivo
efficacy and clinical translational potential. In this study, we address this gap
by defining a new class of naphthoquinone-based IDO inhibitors exemplified by the
natural product menadione, which is shown in mouse tumor models to have similar
antitumor activity to previously characterized IDO inhibitors. Genetic validation
that IDO is the critical in vivo target is demonstrated using IDO-null mice.
Elaboration of menadione to a pyranonaphthoquinone has yielded low nanomolar
potency inhibitors, including new compounds which are the most potent reported to
date (K(i) = 61-70 nM). Synthetic accessibility of this class will facilitate
preclinical chemical-genetic studies as well as further optimization of
pharmacological parameters for clinical translation.